Metabolic Disorders and Inflammatory Bowel Diseases
A special issue of Metabolites (ISSN 2218-1989). This special issue belongs to the section "Endocrinology and Clinical Metabolic Research".
Deadline for manuscript submissions: 25 August 2026
Special Issue Editor
Special Issue Information
Dear Colleagues,
The interplay between metabolic disorders and inflammatory bowel diseases (IBD) has emerged as a critical field of investigation in recent years. Both conditions—encompassing obesity, diabetes, dyslipidemia, Crohn’s disease, and ulcerative colitis—share complex pathophysiological mechanisms involving chronic inflammation, immune dysregulation, and alterations in gut microbiota. Understanding these shared pathways offers promising opportunities for novel therapeutic and preventive strategies.
This Special Issue aims to explore the bidirectional relationship between metabolic dysfunction and intestinal inflammation. We welcome the submission of original research articles, reviews, and clinical studies addressing metabolic alterations in IBD, the impact of gut microbiome composition on metabolic homeostasis, and the influence of diet, lifestyle, and pharmacological interventions on disease progression. Mechanistic studies that elucidate molecular signaling networks, cytokine pathways, or genetic predispositions are particularly encouraged.
Dr. Fotios Fousekis
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Metabolites is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- inflammatory bowel disease
- ulcerative colitis
- crohn’s disease
- adipose tissue
- obesity
- metabolic disorders
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
